Aug. 20, 2026

ABOUT THIS EPISODE

New Path, Same Purpose: Dedicated to Advancing Transplant Research

After nearly 40 years caring for transplant patients and more than 25 years in clinical research, Dr. Helio Tedesco has made a unique transition from investigator to CRO medical leader. In this episode of Moving Medicine Forward, Dr. Tedesco reflects on the evolution of transplantation medicine, the challenges patients face before and after transplant, and why clinical research remains essential to improving long-term outcomes. He also shares how his experience conducting more than 25,000 transplants now helps shape more practical, patient centered clinical trials at CTI.

01:17 From Investigator to CTI
03:33 The Evolution of Transplant Medicine
05:20 Challenges Facing Transplant Patients
07:53 A Lifelong Commitment to Research
10:07 Designing Better Clinical Trials
12:58 25,000+ Transplants Later
14:13 What's Next for Transplantation?

Life Sciences

Science

English

United States

Use API to fetch this episode in JSON

IN THIS EPISODE

helio tedesco

Edit these tags

TRANSCRIPT 🔗

Are you the producer of this podcast? Add a podcast transcript

Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

SEARCH PAST EPISODES

Search past episodes of Moving Medicine Forward.

Embed this search bar to your website

OTHER EPISODES IN THIS PODCAST

Inside Pharmacovigilance: Detecting Risks, Protecting Patients

July 29, 2026

What happens behind the scenes to ensure new therapies are safe for patients? In this episode of Moving Medicine Forward, we are joined by John Kane, Vice President of Pharmacovigilance and Safety Services at CTI, to explore the critical role of drug safety throughout the clinical development proce…

00:17:11

SAVE

CLIP

Beyond the Fine Print: How Legal Affairs Enables Clinical Research

Aug. 5, 2026

Ian Hennessey, Vice President & General Counsel at CTI, joins Moving Medicine Forward to discuss the critical role legal affairs plays in advancing global clinical research. From navigating complex regulations and supporting trial operations to evaluating emerging technologies like AI, Ian shar…

00:20:30

SAVE

CLIP

Chill, Not Kill: How Quell Therapeutics is Reimagining Cell Therapy

Aug. 14, 2026

In this episode of Moving Medicine Forward, Jeremy Schrand is joined by Luke Devey, Chief Medical Officer at Quell Therapeutics, and Savannah Doliboa, Chief Commercial Officer at CTI, to discuss how engineered regulatory T cell therapies are being developed to “chill, not kill” the immune system. T…

00:22:30

SAVE

CLIP

Stronger Together: Families, Researchers, and CancerFree KIDS

Aug. 27, 2026

Childhood cancer research advances through the combined efforts of families, researchers, advocates, and donors. In this episode, Matt Robinson of CancerFree KIDS and Dr. Lindy Miles of Cincinnati Children's discuss how early-stage research funding, clinical trials, and community support help bring…

00:33:44

SAVE

CLIP

Disclaimer: The podcast and artwork embedded on this page are from CTI Clinical Trials, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.